Skip to main content

PROTECT trial: No DFS benefit with adjuvant pazopanib for high-risk RCC

Primary tabs

View
Get Stamp Tags
Published Locations

Breadcrumb

Home
PROTECT trial: No DFS benefit with adjuvant pazopanib for high-risk RCC

User login

Username

Password

Reset your password

Type	Lead	score